NCT07349498 Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
| NCT ID | NCT07349498 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University People's Hospital |
| Condition | Hematopoietic Stem Cell Transplantation |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2036-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2026-01-01 with a primary completion date of 2036-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, multicenter observational study for recipients of hematopoietic stem cell transplantation. Patients who underwent hematopoietic stem cell transplantation at the participating centers will be entrolled in the study. The clinical characteristics, laboratory profiles, management measures, and clinical outcomes such as post-transplant cardiovascular events will be prospectively collected.
Eligibility Criteria
Inclusion Criteria: * Patients who undergo hematopoietic cell transplantation at any of the participating medical centers. Exclusion Criteria: * Any other conditions that, in the opinion of the investigator, can interfere with the interpretation of data. * Patient request to withdraw from the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07349498 clinical trial?
This trial is open to participants of all sexes, studying Hematopoietic Stem Cell Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07349498 currently recruiting?
Yes, NCT07349498 is actively recruiting participants. Contact the research team at zhangxh@bjmu.edu.cn for enrollment information.
Where is the NCT07349498 trial being conducted?
This trial is being conducted at Beijing, China, Beijing, China, Beijing, China, Beijing, China and 11 additional locations.
Who is sponsoring the NCT07349498 clinical trial?
NCT07349498 is sponsored by Peking University People's Hospital. The trial plans to enroll 10,000 participants.